Home
Research
Publications
People
Xiaomin Jiang
Group Members
Former Group Members
Gallery
Group photos
Equipments
News
Openings/招聘
38. Nanoparticle-Mediated Toll-Like Receptor Activation and Dual Immune Checkpoint Downregulation for Potent Cancer Immunotherapy.
ACS Nano 2025, 19, 9, 8852–8866.
【
关闭窗口
】